MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Veru P/B Ratio 2011-2026 | VERU
Annual P/B Ratio Veru
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.34 | 5.1 | 9.82 | 2.5 | 5.59 | 3.88 | 2.27 | 0.872 | 0.803 | 1.47 | 4.65 | 8.64 | 7.76 | 7.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.82 | 0.803 | 4.56 |
P/B Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
2.78 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
-0.0793 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
2.2 | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-27.6 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.8 | - | - | $ 754 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
9.71 | - | - | $ 2.06 B |  France |
 |
Canopy Growth Corporation
CGC
|
0.291 | $ 1.19 | 1.28 % | $ 128 M |  Canada |
 |
China Pharma Holdings
CPHI
|
0.586 | $ 0.6 | 3.45 % | $ 10.5 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
3.93 | $ 4.0 | 2.04 % | $ 56.2 M | USA |
 |
Cronos Group
CRON
|
2.12 | $ 2.74 | -0.18 % | $ 1.43 B | Canada |
 |
Eagle Pharmaceuticals
EGRX
|
1.46 | - | -39.89 % | $ 27.7 M | USA |
 |
Catalent
CTLT
|
3.01 | - | - | $ 11.5 B | USA |
 |
Evoke Pharma
EVOK
|
-0.868 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
0.662 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
0.122 | - | 2.45 % | $ 38.1 M | Canada |
 |
Harrow Health
HROW
|
4.93 | $ 53.27 | 0.93 % | $ 1.74 B | USA |
 |
DURECT Corporation
DRRX
|
0.703 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
0.214 | $ 11.03 | 0.64 % | $ 565 M | USA |
 |
Endo International plc
ENDP
|
0.0133 | - | - | $ 28.9 M |  Irlanda |
 |
Athenex
ATNX
|
-0.473 | - | -23.39 % | $ 1.76 M | USA |
 |
Evolus
EOLS
|
161 | $ 4.41 | 2.44 % | $ 273 M | USA |
 |
Pacira BioSciences
PCRX
|
1.51 | $ 23.33 | -0.34 % | $ 1.08 B | USA |
 |
Lannett Company
LCI
|
-1.43 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
0.795 | $ 1.45 | 1.76 % | $ 402 M | Canada |
 |
Jupiter Wellness
JUPW
|
-38.1 | - | - | $ 33.6 M | USA |
 |
Bausch Health Companies
BHC
|
-41.3 | $ 5.99 | -0.5 % | $ 2.19 B | Canada |
 |
Sundial Growers
SNDL
|
0.000669 | $ 1.56 | 0.65 % | $ 3.37 M | Canada |
 |
Tilray
TLRY
|
0.358 | $ 7.91 | -0.19 % | $ 4.89 B | Canada |
 |
Neoleukin Therapeutics
NLTX
|
0.00923 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
1.08 | $ 4.07 | 0.87 % | $ 536 M | USA |
 |
PetIQ
PETQ
|
0.456 | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
0.916 | $ 14.23 | -2.64 % | $ 1.96 B | USA |
 |
Aurora Cannabis
ACB
|
0.449 | $ 3.86 | 1.72 % | $ 86.3 M | Canada |
 |
ProPhase Labs
PRPH
|
2.05 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
-1.5 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
2.27 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
1.67 | $ 0.91 | -3.07 % | $ 21.2 M | USA |
 |
Relmada Therapeutics
RLMD
|
1.89 | $ 4.43 | 3.99 % | $ 133 M | USA |
 |
OptiNose
OPTN
|
-2.21 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
0.479 | $ 11.92 | -0.17 % | $ 847 M | USA |
 |
PLx Pharma
PLXP
|
2.29 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
0.83 | $ 2.9 | 2.11 % | $ 3.6 M | USA |
 |
Solid Biosciences
SLDB
|
1.64 | $ 6.34 | 2.51 % | $ 259 M | USA |
 |
SCYNEXIS
SCYX
|
0.964 | $ 0.78 | -0.53 % | $ 37.3 M | USA |
 |
Tricida
TCDA
|
1.65 K | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
0.816 | $ 2.24 | -0.53 % | $ 23.4 M | USA |
 |
cbdMD
YCBD
|
0.857 | $ 1.01 | 7.52 % | $ 4.36 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.406 | - | - | $ 55.5 M | USA |
 |
Viatris
VTRS
|
0.646 | $ 16.05 | -0.09 % | $ 19.5 B | USA |